The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting

The American Journal of Gastroenterology
A N BarkunRUGBE Investigators

Abstract

From the Canadian Registry of patients with Upper Gastrointestinal Bleeding and Endoscopy (RUGBE), we determined clinical outcomes and explored the roles of endoscopic and pharmacologic therapies in a contemporary real-life setting. Analysis of randomly selected patients endoscoped for nonvariceal upper gastrointestinal bleeding at 18 community and tertiary care institutions between 1999 and 2002. Covariates and outcomes were defined a priori and 30-day follow-up obtained. Logistic regression models identified predictors of outcomes. One thousand eight-hundred and sixty-nine patients were included (66 +/- 17 yr, 38% female, 2.5 +/- 1.6 comorbid conditions, hemoglobin, 96 +/- 27 g/L, 54% received a mean of 2.9 +/- 1.7 units of blood). Endoscopy was performed within 24 h in 76%, with ulcers (55%) most commonly noted. High-risk endoscopic stigmata and endoscopic therapy were reported in 37%. Rebleeding, surgery, and mortality rates were 14.1%, 6.5%, and 5.4%, respectively. Decreased rebleeding was significantly and independently associated with PPI use (85% of patients, mean daily dose 56 +/- 53 mg) in all patients regardless of endoscopic stigmata, (odds ratio (OR):0.53, 95% confidence interval, 95% CI:0.37-0.77) and endoscopic h...Continue Reading

References

Oct 1, 1978·Anesthesiology·W D OwensE L Spitznagel
Jul 25, 1990·JAMA : the Journal of the American Medical Association·H S SacksD Pagano
May 1, 1981·Gastrointestinal Endoscopy·F E SilversteinJ Persing
Sep 15, 1994·The New England Journal of Medicine·L Laine, W L Peterson
Mar 1, 1996·Gut·T A RockallT C Northfield
Apr 10, 1997·The New England Journal of Medicine·M S KhurooJ S Sodi
Aug 30, 1997·BMJ : British Medical Journal·O BlatchfordJ Pell
Feb 12, 1998·Annals of Internal Medicine·D B Rubin
Dec 14, 1999·Alimentary Pharmacology & Therapeutics·A N BarkunR N Fedorak
Apr 1, 2000·Gastrointestinal Endoscopy·G S CooperG E Rosenthal
Jun 22, 2000·The New England Journal of Medicine·K Benson, A J Hartz
Jun 22, 2000·The New England Journal of Medicine·J ConcatoR I Horwitz
Jun 22, 2000·The New England Journal of Medicine·S J Pocock, D R Elbourne
Jun 26, 2001·Alimentary Pharmacology & Therapeutics·J P GisbertJ M Pajares
Jan 17, 2002·The Annals of Pharmacotherapy·P J ZedC A Marra
Aug 2, 2002·Postgraduate Medical Journal·S MahadevaM A Hull
Oct 16, 2002·Annals of Internal Medicine·Leonard E Braitman, Paul R Rosenbaum
Nov 19, 2003·Annals of Internal Medicine·Alan BarkunUNKNOWN Nonvariceal Upper GI Bleeding Consensus Conference Group

❮ Previous
Next ❯

Citations

Jun 30, 2010·Digestive Diseases and Sciences·Brintha K EnestvedtGlenn M Eisen
Aug 30, 2008·The New England Journal of Medicine·Ian M GralnekMarc Bardou
Jul 6, 2007·BMC Gastroenterology·Michael LoydPhilip Jacobs
Nov 13, 2012·Annals of Intensive Care·David OsmanUNKNOWN group of experts
Dec 20, 2012·PloS One·Stephen E RobertsJohn G Williams
Jan 16, 2013·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Alan N BarkunLarry Stitt
Aug 31, 2011·World Journal of Gastroenterology : WJG·Cheol Woong ChoiMong Cho
Apr 3, 2012·World Journal of Gastroenterology : WJG·Ingrid Lisanne Holster, Ernst Johan Kuipers
Sep 28, 2010·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Mohammad J KavianiMehdi Saberifiroozi
Aug 19, 2014·World Journal of Gastroenterology : WJG·Ray BoyapatiMayur Garg
Sep 19, 2012·Gastroenterology Research and Practice·István RáczIstván Altorjay
Nov 27, 2008·Digestive Diseases and Sciences·Jacob G HooverKevin J Franklin
Mar 14, 2007·Scandinavian Journal of Gastroenterology·Sven AdamsenPeer Wille-Jørgensen
Nov 22, 2013·Scandinavian Journal of Gastroenterology·Stig Borbjerg LaursenOve B Schaffalitzky de Muckadell
Jan 16, 2016·The Korean Journal of Internal Medicine·Yoo Jin LeeSeong Woo Jeon
Mar 18, 2005·Alimentary Pharmacology & Therapeutics·M BardouA N Barkun
May 17, 2006·Alimentary Pharmacology & Therapeutics·P O KatzA N Barkun
May 3, 2007·Expert Opinion on Pharmacotherapy·Andrea MorgnerJoachim Labenz
Dec 3, 2014·The American Journal of Gastroenterology·Walter G ParkSachin Wani
Jan 23, 2015·BioMed Research International·Seng-Kee ChuahJian-Lin Ren
Apr 7, 2016·The Korean Journal of Internal Medicine·Dong-Won AhnDong Ho Lee
Jun 12, 2014·United European Gastroenterology Journal·Amnon Sonnenberg
Jul 9, 2014·Arquivos De Gastroenterologia·Jorge FonsecaCarla Adriana Santos
Oct 14, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Abdel Aziz M ShaheenRobert P Myers
Mar 19, 2008·Best Practice & Research. Clinical Gastroenterology·M E van Leerdam
Feb 13, 2014·Journal of Clinical Gastroenterology·Peter S Liang, John R Saltzman
Sep 12, 2014·Current Treatment Options in Gastroenterology·Carla J GargalloAngel Lanas
Nov 2, 2013·Therapeutic Advances in Gastroenterology·Marinos PericleousJames O'Beirne
Mar 27, 2018·Scandinavian Journal of Gastroenterology·Rita Jiménez-RosalesEduardo Redondo-Cerezo
Jan 1, 2012·Clinical Medicine Insights. Gastroenterology·Christo J van Rensburg, Susan Cheer
Nov 12, 2015·World Journal of Gastrointestinal Pharmacology and Therapeutics·Erwin Biecker
Jan 8, 2010·The American Journal of Gastroenterology·Angel Lanas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.